SciELO - Scientific Electronic Library Online

 
vol.25 número10Carência de atenção à saúde ocular no setor público: um estudo de base populacionalCorrespondência entre o estado nutricional de crianças e a percepção materna: um estudo populacional índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

Compartilhar


Cadernos de Saúde Pública

versão impressa ISSN 0102-311Xversão On-line ISSN 1678-4464

Resumo

LAGO, Regina Ferro do  e  COSTA, Nilson do Rosário. Antiretroviral manufacturers and the challenge of universal access to drugs through the Brazilian National STD/AIDS Program. Cad. Saúde Pública [online]. 2009, vol.25, n.10, pp.2273-2284. ISSN 0102-311X.  https://doi.org/10.1590/S0102-311X2009001000017.

This article describes the antiretroviral (ARV) manufacturing market in Brazil and contextualizes the challenges for the public policy of supplying ARVs through the National STD/AIDS Program. Increasing expenditure on these drugs is the main source of uncertainty for the policy's future. Brazil's domestic scenario is one of growing external dependence, both for the finished drugs and the active ingredients. Experience in the National Program has shown that it is the state's role to provide public goods, which presupposes ensuring mutual compatibility between company interests and social interests. This balance is currently at stake in Brazil, since structural changes in the market have raised challenges for the National Program's sustainability, requiring new public policy instruments in defense of the collective interest. The article drew on a literature review, using bibliographic indexing sources, systematic organization of primary data, government publications, relevant legislation, research reports, and articles recommended by experts from the field.

Palavras-chave : Anti-Retrovirals Agents; Pharmaceutical Services; Drug Industry.

        · resumo em Português     · texto em Inglês     · Inglês ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons